Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
Systemic lupus erythematosus is a complex autoimmune disease in which more than one-third of patients develop lupus nephritis (LN), leading to chronic kidney disease and end-stage renal failure. The treatment of LN has always been a challenge. Tacrolimus is an effective immunosuppressant that has be...
Saved in:
| Main Authors: | N. Yu. Nikishina, E. A. Aseeva, S. K. Soloviev, A. M. Lila, A. V. Datcina, E. T. Pletnev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2025-06-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1784 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lupus nephritis. Part II, modern ideas about therapy
by: Elena A. Aseeva, et al.
Published: (2024-09-01) -
Organ involvement and laboratory abnormalities associated with tuberculosis disease in systemic lupus erythematosus patients: a systematic review and meta-analysis
by: Alveron Andreas Tear, et al.
Published: (2025-12-01) -
Programmed immunoadsorption with regeneration of adsoption columns in the treatment of lupus nephritis
by: A. A. Sokolov, et al.
Published: (2020-09-01) -
EFFICACY OF SIMULTANEOUS INTENSIVE THERAPY IN PTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
by: E N Otteva, et al.
Published: (2002-02-01) -
Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus
by: Ying Wang, et al.
Published: (2023-12-01)